Cobra Biologics Ltd - Company Review
Cobra Biologics Ltd - Company ReviewSummary
Cobra Biologics Ltd (Cobra Biologics), formerly RecipharmCobra Biologics Ltd, a subsidiary of Cobra Biologics Holding AB, is a contract development and manufacturing organisation that offers biologics and pharmaceuticals services. The organization’s services include standalone services, proteins, plasmid DNA, viruses, fill finish and technology services. Its fill finish services comprise aseptic pharmaceuticals manufacture, API freeze drying and lyophilisation, pre-filled syringe fill finish and injectable vial fill finish services. Cobra Biologics offers plasmid DNA services such as molecular biology services, DNA platform process development and scale up; high quality DNA, DNA analytical development and qualification, and other services. The organization operates through its offices in Sweden and the UK. Cobra Biologics is headquartered in Keele, the UK.
This comprehensive company report of Cobra Biologics Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.